TrialPloS one2015

Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Christian Daugaard Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.